The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines

被引:263
作者
Bortnick, AE
Rothblat, GH
Stoudt, G
Hoppe, KL
Royer, LJ
McNeish, J
Francone, OL
机构
[1] Pfizer Inc, Div Cent Res, Dept Cardiovasc & Metab Dis, Groton, CT 06340 USA
[2] Med Coll Penn & Hahnemann Univ, Dept Biochem, Philadelphia, PA 19129 USA
[3] Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.1074/jbc.M003407200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Studies show that lipid-free apoA-I stimulates release of cholesterol and phospholipid from fibroblasts and macrophages. ATP-binding cassette 1 (ABC1) is implicated in this release and has been identified as the genetic defect in Tangier disease, evidence that ABC1 is critical to the biogenesis of high density lipoprotein. We quantified levels of ABC1 mRNA protein, and cholesterol efflux from J774 mouse macrophages rt exposure to a cAMP analog. Up-regulating ABC1 mRNA correlated to increased cholesterol efflux in a dose- and time-dependent manner, mRNA levels rose after 15 min of exposure while protein levels rose after 1 h, with increased efflux 2-4 h post-treatment. In contrast to cells from wild-type mice, peritoneal macrophages from the Abc1 -/- mouse showed a lower level of basal efflux and no increase with cAMP treatment. The stimulation of efflux exhibits specificity for apoA-I, high density lipoprotein, and other apolipoproteins as cholesterol accepters, but not for small unilamellar vesicles, bile acid micelles, or cyclodextrin, We have studied a number of cell types and found that while other cell lines express ABC1 constitutively, only J774 and elicited mouse macrophages show a substantial increase of mRNA and efflux with cAMP treatment. ApoA-I-stimulated efflux was detected from the majority of cell lines examined, independent of treatment.
引用
收藏
页码:28634 / 28640
页数:7
相关论文
共 59 条
  • [1] CLONING OF THE BETA-CELL HIGH-AFFINITY SULFONYLUREA RECEPTOR - A REGULATOR OF INSULIN-SECRETION
    AGUILARBRYAN, L
    NICHOLS, CG
    WECHSLER, SW
    CLEMENT, JP
    BOYD, AE
    GONZALEZ, G
    HERRERASOSA, H
    NGUY, K
    BRYAN, J
    NELSON, DA
    [J]. SCIENCE, 1995, 268 (5209) : 423 - 426
  • [2] BERNARD DW, 1991, J BIOL CHEM, V266, P710
  • [3] Bielicki JK, 1999, J LIPID RES, V40, P85
  • [4] EFFLUX OF PHOSPHOLIPID FROM FIBROBLASTS WITH NORMAL AND ELEVATED LEVELS OF CHOLESTEROL
    BIELICKI, JK
    JOHNSON, WJ
    GLICK, JM
    ROTHBLAT, GH
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1085 (01) : 7 - 14
  • [5] The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
    Bodzioch, M
    Orsó, E
    Klucken, T
    Langmann, T
    Böttcher, L
    Diederich, W
    Drobnik, W
    Barlage, S
    Büchler, C
    Porsch-Özcürümez, M
    Kaminski, WE
    Hahmann, HW
    Oette, K
    Rothe, G
    Aslanidis, C
    Lackner, KJ
    Schmitz, G
    [J]. NATURE GENETICS, 1999, 22 (04) : 347 - 351
  • [6] Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
    Brooks-Wilson, A
    Marcil, M
    Clee, SM
    Zhang, LH
    Roomp, K
    van Dam, M
    Yu, L
    Brewer, C
    Collins, JA
    Molhuizen, HOF
    Loubser, O
    Ouelette, BFF
    Fichter, K
    Ashbourne-Excoffon, KJD
    Sensen, CW
    Scherer, S
    Mott, S
    Denis, M
    Martindale, D
    Frohlich, J
    Morgan, K
    Koop, B
    Pimstone, S
    Kastelein, JJP
    Genest, J
    Hayden, MR
    [J]. NATURE GENETICS, 1999, 22 (04) : 336 - 345
  • [7] Christian AE, 1997, J LIPID RES, V38, P2264
  • [8] Cole SPC, 1998, BIOESSAYS, V20, P931, DOI 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO
  • [9] 2-J
  • [10] ATP-binding cassette proteins as targets for drug discovery
    Demolombe, S
    Escande, D
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (08) : 273 - 275